Reviews for AROMASIN

3 ratings: (side effects include neuropathy)

 Edit Filter  |   Clear Filter  

Compare AROMASIN with similar:
 AROMATASE INHIBITORS

 Type: Rx Drug

  

AROMASIN  (EXEMESTANE):  This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age.   FDA Approval Date: 1999-10-21 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR AROMASINCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  Breast cancer Was on letrozole for 1 1/2 years experienced joint pain in hips and muscle pain in glutes. Switched to aromasin been on for 5 months and am now experiencing terrible joint pain in hips, knees and glutes. Am going to physical therapy, acupuncture and chiropractor for massage therapy and so far only very minor improvements. Acupuncture has helped with neuropathy in fingers and toes. Will be talking to oncologist about alternatives. F 66 5 months
25 mg 1X day
3/18/2022
 1  Breast Cancer DCIS Stage 0 Hair loss, rash on forehead, behind ears, decreased presence of mind, severe fatigue. Leg/foot/ankle edema. Knee joint pain severe - could no longer walk, rise from sitting, negotiate stairs. Foot neuropathy and blistering. Sudden severe fatigue. High blood pressure. A year after removing myself from the drug, hair has not grown back. Foot pain still present. Knee pain returns frequently. Shooting foot and toe pain - especially if exposed to temperature change. Foot numbness, lack of temperature control. Frequent leg cramps. Continued high blood pressure. Doctors dismiss pain, fatigue, swelling with "it's better than cancer" type comments flavored with "we all get such aches as we age." All this in less than a year. Given some of the severest SEs are irreversible, I strongly urge you to avoid this drug if quality of life is important to you. F 64 11 weeks
25 1X day
11/5/2015
Email
 3  Invasive Lobular BC, Stage 3 Side effects - due to Aromasin or not? Thinning hair facial hair ( particularly in last year) vagine dryness -almost immediately libido - significantly diminished - within two years insomnia - since begining joint pains in feet, hips and achiness in legs - since beginning hot flashes/night sweats - have diminshed neuropathy in fingers distortion in one hand of fingers with large lump on thumb (just this past year) carpal tunnel Bloody-awful unexplained shoulder and neck pain which extended into head and facial muscles and jaw for 6 months Now jsut diagnosed with mild degenerative osteoarthritis which is causing me to walk with a cane Bone scan in 20011 showed above average bone density for age. Still alive I started tamoxifen in 2006 and was changed to Aromisin in 2008. I am on it optionally now, but I am truly scared to go off it as I am sure it is keeping me alive and micromestastes at bay. Quality of life is an issue thought and right now I cannot do the things I have enjoyed all my life, including dance. It might not be Aromasin but certainly from reading previuos posts, I am wondering. F 55 4 years
1X day
10/2/2012
  

AROMASIN  (EXEMESTANE):  This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age.   FDA Approval Date: 1999-10-21 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP